Mismatch repair analysis of inherited MSH2 and/or MSH6 variation pairs found in cancer patients

Human Mutation

Volumn 33, Issue 8, 2012, Pages 1294-1301

  Kantelinen, Jukka ^a   Kansikas, Minttu ^a   Candelin, Satu ^a   Hampel, Heather ^b   Smith, Betsy ^c   Holm, Liisa ^a,d   Kariola, Reetta ^a   Nyström, Minna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b OHIO STATE UNIVERSITY   (United States)

^c Benefis Health System   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Functional analysis; Lynch syndrome; Mismatch repair; MSH2; MSH6; VUS

Indexed keywords

PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; ASSAY; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WILD TYPE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTS HOMOLOG 2 PROTEIN; PROTEIN MULTIMERIZATION;

EID: 84863858680     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22119     Document Type: Article

References (44)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
2. Cannavo E, Marra G, Sabates-Bellver J, Menigatti M, Lipkin SM, Fischer F, Cejka P, Jiricny J. 2005. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res 65:10759-10766.
3. Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. 2000. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:18424-18431.
4. Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. 2008. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852-860.
5. Cyr JL, Heinen CD. 2008. Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding. J Biol Chem 283:31641-31648.
6. de Wind N, Dekker M, Claij N, Jansen L, van Klink Y, Radman M, Riggins G, van der Valk M, van't Wout K, te Riele H. 1999. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat Genet 23:359-362.
7. Drost M, Zonneveld JB, van Dijk L, Morreau H, Tops CM, Vasen HF, Wijnen JT, de Wind N. 2010. A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1. Hum Mutat 31:247-253.
8. Drotschmann K, Clark AB, Kunkel TA. 1999. Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr Biol 9:907-910.
9. Drummond JT, Genschel J, Wolf E, Modrich P. 1997. DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci USA 94:10144-10149.
10. Ellison AR, Lofing J, Bitter GA. 2001. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 10:1889-1900.
11. Felton KE, Gilchrist DM, Andrew SE. 2007. Constitutive deficiency in DNA mismatch repair. Clin Genet 71:483-498.
12. Gammie AE, Erdeniz N, Beaver J, Devlin B, Nanji A, Rose MD. 2007. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics 177:707-721.
13. Gargiulo S, Torrini M, Ollila S, Nasti S, Pastorino L, Cusano R, Bonelli L, Battistuzzi L, Mastracci L, Bruno W, Savarino V, Sciallero S, et al. 2009. Germline MLH1 and MSH2 mutations in italian pancreatic cancer patients with suspected lynch syndrome. Fam Cancer 8:547-553.
14. Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS, IARC Unclassified Genetic Variants Working Group. 2008. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29:1265-1272.
15. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, et al. 2005. Screening for the lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860.
16. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, et al. 2006. Screening for lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810-7817.
17. Hampel H, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, LaJeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, de la Chapelle A, et al. 2007. Comment on: screening for lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 67:9603.
18. Holmes Jr J, Clark S, Modrich P. 1990. Strand-specific mismatch correction in nuclear extracts of human and drosophila melanogaster cell lines. Proc Natl Acad Sci USA 87:5837-5841.
19. Jiricny J. 2006. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7:335-346.
20. Kantelinen J, Kansikas M, Korhonen MK, Ollila S, Heinimann K, Kariola R, Nyström M. 2010. MutSbeta exceeds MutSalpha in dinucleotide loop repair. Br J Cancer 102:1068-1073.
21. Kariola R, Otway R, Lönnqvist KE, Raevaara TE, Macrae F, Vos YJ, Kohonen-Corish M, Hofstra RM, Nyström-Lahti M. 2003. Two mismatch repair gene mutations found in a colon cancer patient-which one is pathogenic? Hum Genet 112:105-109.
22. Kariola R, Raevaara TE, Lönnqvist KE, Nyström-Lahti M. 2002. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 11:1303-1310.
23. Korhonen MK, Vuorenmaa E, Nyström M. 2008. The first functional study of MLH3 mutations found in cancer patients. Genes Chromosomes Cancer 47:803-809.
24. Lahue RS, Au KG, Modrich P. 1989. DNA mismatch correction in a defined system. Science 245:160-164.
25. Liu HX, Zhou XL, Liu T, Werelius B, Lindmark G, Dahl N, Lindblom A. 2003. The role of hMLH3 in familial colorectal cancer. Cancer Res 63:1894-1899.
26. Lynch HT, Boland CR, Rodriguez-Bigas MA, Amos C, Lynch JF, Lynch PM. 2007. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol 25:3534-3542.
27. Marra G, Iaccarino I, Lettieri T, Roscilli G, Delmastro P, Jiricny J. 1998. Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci USA 95:8568-8573.
28. Martinez SL, Kolodner RD. 2010. Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions. Proc Natl Acad Sci USA 107:5070-5075.
29. Mukherjee S, Law SM, Feig M. 2009. Deciphering the mismatch recognition cycle in MutS and MSH2-MSH6 using normal-mode analysis. Biophys J 96:1707-1720.
30. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11:863-874.
31. Nyström-Lahti M, Perrera C, Räschle M, Panyushkina-Seiler E, Marra G, Curci A, Quaresima B, Costanzo F, D'Urso M, Venuta S, Jiricny J. 2002. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 33:160-167.
32. Ollila S, Dermadi Bebek D, Greenblatt M, Nyström M. 2008. Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification. Int J Cancer 123:720-724.
33. Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-Corish M, Gerdes AM, Peltomäki P, Mangold E, de la Chapelle A, et al. 2006. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408-1417.
34. Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group. 2008. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282-1291.
35. Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lonnqvist KE, Holinski-Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes AM, Peltomäki P, et al. 2005. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 129:537-549.
36. Raevaara TE, Vaccaro C, Abdel-Rahman WM, Mocetti E, Bala S, Lonnqvist KE, Kariola R, Lynch HT, Peltomäki P, Nyström-Lahti M. 2003. Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 125:501-509.
37. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML. 2001. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121:830-838.
38. Stone EA, Sidow A. 2005. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 15:978-986.
39. Tanyi M, Olasz J, Kamory E, Csuka O, Tanyi JL, Ress Z, Damjanovich L. 2008. Difficulties in recognizing families with hereditary non-polyposis colorectal carcinoma. presentation of 4 families with proven mutation. Eur J Surg Oncol 34:1322-1327.
40. Tanyi M, Olasz J, Lukacs G, Csuka O, Toth L, Szentirmay Z, Ress Z, Barta Z, Tanyi JL, Damjanovich L. 2006. Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer. World J Gastroenterol 12:1192-1197.
41. Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB, IARC Unclassified Genetic Variants Working Group. 2008. In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat 29:1327-1336.
42. Warren JJ, Pohlhaus TJ, Changela A, Iyer RR, Modrich PL, Beese LS. 2007. Structure of the human MutSalpha DNA lesion recognition complex. Mol Cell 26:579-592.
43. Wielders EA, Dekker RJ, Holt I, Morris GE, te Riele H. 2011. Characterization of MSH2 variants by endogenous gene modification in mouse embryonic stem cells. Hum Mutat 32:389-396.
44. Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, van der Sluis T, Kempinga C, van dDer Zee AG, Hollema H, Buys CH, Kleibeuker JH, et al. 2001. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 29:137-138.